z-logo
open-access-imgOpen Access
Pharmacoeconomic evaluation of using enzalutamide for treatment of patients with metastatic hormone-sensitive prostate cancer
Author(s) -
N. А. Avxentyev,
E.V. Derkach,
Yu.V. Makarova
Publication year - 2022
Publication title -
onkourologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 4
eISSN - 1996-1812
pISSN - 1726-9776
DOI - 10.17650/1726-9776-2022-18-1-90-105
Subject(s) - enzalutamide , medicine , prostate cancer , oncology , androgen deprivation therapy , docetaxel , cancer , androgen receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here